RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $424 to $455.
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $424 to $455.